We are live on ! Find out more
AC

Adelphi Capital Portfolio holdings

AUM $3.21M
1-Year Est. Return 121.6%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+121.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$426M
AUM Growth
-$56.2M
Cap. Flow
-$42.4M
Cap. Flow %
-9.95%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$24.4M
2
WP
Worldpay, Inc.
WP
+$12M
3
RYAAY icon
Ryanair
RYAAY
+$6.09M

Sector Composition

Rank Sector Weight
1 Healthcare 32.92%
2 Industrials 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WP
1
DELISTED
Worldpay, Inc.
WP
$241M 56.47%
1,965,002
-100,894
-5% -$12M
TAK icon
2
Takeda Pharmaceutical
TAK
$55.9B
$140M 32.92%
7,931,116
-1,339,419
-14% -$24.4M
RYAAY icon
3
Ryanair
RYAAY
$30.1B
$45.2M 10.6%
1,762,350
-214,963
-11% -$6.09M

Similar funds

TA
TA Associates Boston, Massachusetts $4.01M AUM 59.82% 1-Year Est. Return
TAM
Trikon Asset Management Hong Kong $1.84M AUM 172.11% 1-Year Est. Return
TMC
TVL Management Corporation Menlo Park, California $1.84M AUM 0.1% 1-Year Est. Return
AV
Arboretum Ventures Ann Arbor, Michigan $1.72M AUM 82.7% 1-Year Est. Return
MVPI
Maven Ventures Partners II Palo Alto, California $958K AUM 41.74% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
IAC
ION Acquisition Corp Herzliya, Israel $5.63M AUM 38.71% 1-Year Est. Return
ALBM
Alcentra Ltd (BNY Mellon) London, United Kingdom $566K AUM 51.56% 1-Year Est. Return

Adelphi Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Adelphi Capital held 3 positions worth $426M, down 12% from $483M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Adelphi Capital withdrew a net $42.4M in Q2 2019, reducing 3 holdings. Its largest reduction was Takeda Pharmaceutical, cutting an estimated $24.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 39% a quarter earlier, followed by Industrials.

  • Adelphi Capital's biggest Q2 2019 reduction was Takeda Pharmaceutical, cutting an estimated $24.4M.
  • Adelphi Capital's ten largest holdings make up 100% of its $426M portfolio in Q2 2019.
  • Adelphi Capital opened 0 new positions and closed 0 in Q2 2019.
  • Adelphi Capital's portfolio value fell 12% quarter-over-quarter to $426M.

Based on Adelphi Capital's 13F filing for Q2 2019, filed 30 Jul 2019.